scholarly journals Engineering Rhodosporidium toruloides for limonene production

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Sasa Liu ◽  
Mengyao Zhang ◽  
Yuyao Ren ◽  
Guojie Jin ◽  
Yongsheng Tao ◽  
...  
Keyword(s):  
Rhodosporidium Toruloides ◽  
Cell Factory ◽  
Mevalonate Kinase ◽  
Chimeric Enzyme ◽  
Methanosarcina Mazei ◽  
Limonene Synthase ◽  
A Cell ◽  
Coa Reductase ◽  
Geranyl Pyrophosphate Synthase ◽  
Geranyl Pyrophosphate

Abstract Background Limonene is a widely used monoterpene in the production of food, pharmaceuticals, biofuels, etc. The objective of this work was to engineer Rhodosporidium toruloides as a cell factory for the production of limonene. Results By overexpressing the limonene synthase (LS), neryl pyrophosphate synthase (NPPS)/geranyl pyrophosphate synthase and the native hydroxy-methyl-glutaryl-CoA reductase (HMGR), we established a baseline for limonene production based on the mevalonate route in Rhodosporidium toruloides. To further enhance the limonene titer, the acetoacetyl-CoA thiolase/HMGR (EfMvaE) and mevalonate synthase (EfMvaS) from Enterococcus faecalis, the mevalonate kinase from Methanosarcina mazei (MmMK) and the chimeric enzyme NPPS-LS were introduced in the carotenogenesis-deficient strain. The resulting strains produced a maximum limonene titer of 393.5 mg/L. Conclusion In this study, we successfully engineered the carotenogenesis yeast R. toruloides to produce limonene. This is the first report on engineering R. toruloides toward limonene production based on NPP and the fusion protein SltNPPS-CltLS. The results demonstrated that R. toruloides is viable for limonene production, which would provide insights into microbial production of valuable monoterpenes.

scholarly journals Characterization of a Feedback-Resistant Mevalonate Kinase from the Archaeon Methanosarcina mazei

2011 ◽  
Vol 77 (21) ◽  
pp. 7772-7778 ◽  
Author(s):  
Yuliya A. Primak ◽  
Mai Du ◽  
Michael C. Miller ◽  
Derek H. Wells ◽  
Alex T. Nielsen ◽  
...  
Keyword(s):  
Mevalonate Pathway ◽  
Feedback Inhibition ◽  
Mevalonate Kinase ◽  
Farnesyl Pyrophosphate ◽  
Content Type ◽  
Dimethylallyl Diphosphate ◽  
Methanosarcina Mazei ◽  
Geranyl Pyrophosphate ◽  
Inhibition Analysis

ABSTRACTThe mevalonate pathway is utilized for the biosynthesis of isoprenoids in many bacterial, eukaryotic, and archaeal organisms. Based on previous reports of its feedback inhibition, mevalonate kinase (MVK) may play an important regulatory role in the biosynthesis of mevalonate pathway-derived compounds. Here we report the purification, kinetic characterization, and inhibition analysis of the MVK from the archaeonMethanosarcina mazei. The inhibition of theM. mazeiMVK by the following metabolites derived from the mevalonate pathway was explored: dimethylallyl diphosphate (DMAPP), geranyl pyrophosphate (GPP), farnesyl pyrophosphate (FPP), isopentenyl monophosphate (IP), and diphosphomevalonate.M. mazeiMVK was not inhibited by DMAPP, GPP, FPP, diphosphomevalonate, or IP, a proposed intermediate in an alternative isoprenoid pathway present in archaea. Our findings suggest that theM. mazeiMVK represents a distinct class of mevalonate kinases that can be differentiated from previously characterized MVKs based on its inhibition profile.

scholarly journals Metabolic engineering of Deinococcus radiodurans for pinene production from glycerol

2021 ◽  
Vol 20 (1) ◽  
Author(s):  
Seyed Hossein Helalat ◽  
Carsten Jers ◽  
Mandana Bebahani ◽  
Hassan Mohabatkar ◽  
Ivan Mijakovic
Keyword(s):  
Minimal Medium ◽  
Deinococcus Radiodurans ◽  
Pharmaceutical Products ◽  
Cell Factory ◽  
Microbial Cell Factory ◽  
Suitable Host ◽  
Jet Engine ◽  
E Coli ◽  
A Cell ◽  
Geranyl Pyrophosphate

Abstract Background The objective of this work was to engineer Deinococcus radiodurans R1 as a microbial cell factory for the production of pinene, a monoterpene molecule prominently used for the production of fragrances, pharmaceutical products, and jet engine biofuels. Our objective was to produce pinene from glycerol, an abundant by-product of various industries. Results To enable pinene production in D. radiodurans, we expressed the pinene synthase from Abies grandis, the geranyl pyrophosphate (GPP) synthase from Escherichia coli, and overexpressed the native 1-deoxy-d-xylulose 5-phosphate synthase. Further, we disrupted the deinoxanthin pathway competing for the substrate GPP by either inactivating the gene dr0862, encoding phytoene synthase, or substituting the native GPP synthase with that of E. coli. These manipulations resulted in a D. radiodurans strain capable of producing 3.2 ± 0.2 mg/L pinene in a minimal medium supplemented with glycerol, with a yield of 0.13 ± 0.04 mg/g glycerol in shake flask cultures. Additionally, our results indicated a higher tolerance of D. radiodurans towards pinene as compared to E. coli. Conclusions In this study, we successfully engineered the extremophile bacterium D. radiodurans to produce pinene. This is the first study demonstrating the use of D. radiodurans as a cell factory for the production of terpenoid molecules. Besides, its high resistance to pinene makes D. radiodurans a suitable host for further engineering efforts to increase pinene titer as well as a candidate for the production of the other terpenoid molecules.

scholarly journals Reassessing Escherichia coli as a cell factory for biofuel production

2017 ◽  
Vol 45 ◽  
pp. 92-103 ◽  
Author(s):  
Chonglong Wang ◽  
Brian F Pfleger ◽  
Seon-Won Kim
Keyword(s):  
Escherichia Coli ◽  
Biofuel Production ◽  
Cell Factory ◽  
A Cell

scholarly journals Metabolic Engineering of Non-carotenoid-Producing Yeast Yarrowia lipolytica for the Biosynthesis of Zeaxanthin

2021 ◽  
Vol 12 ◽  
Author(s):  
Yuxiao Xie ◽  
Shulin Chen ◽  
Xiaochao Xiong
Keyword(s):  
Yarrowia Lipolytica ◽  
Fold Increase ◽  
Genetically Engineered ◽  
Cell Factory ◽  
Yeast Nitrogen Base ◽  
Nitrogen Base ◽  
Yeast Extract Peptone Dextrose ◽  
Dry Cell Weight ◽  
A Cell ◽  
Β Carotene

Zeaxanthin is vital to human health; thus, its production has received much attention, and it is also an essential precursor for the biosynthesis of other critical carotenoids such as astaxanthin and crocetin. Yarrowia lipolytica is one of the most intensively studied non-conventional yeasts and has been genetically engineered as a cell factory to produce carotenoids such as lycopene and β-carotene. However, zeaxanthin production by Y. lipolytica has not been well investigated. To fill this gap, β-carotene biosynthesis pathway has been first constructed in this study by the expression of genes, including crtE, crtB, crtI, and carRP. Three crtZ genes encoding β-carotene hydroxylase from different organisms were individually introduced into β-carotene-producing Y. lipolytica to evaluate their performance for producing zeaxanthin. The expression of crtZ from the bacterium Pantoea ananatis (formerly Erwinia uredovora, Eu-crtZ) resulted in the highest zeaxanthin titer and content on the basis of dry cell weight (DCW). After verifying the function of Eu-crtZ for producing zeaxanthin, the high-copy-number integration into the ribosomal DNA of Y. lipolytica led to a 4.02-fold increase in the titer of zeaxanthin and a 721% increase in the content of zeaxanthin. The highest zeaxanthin titer achieved 21.98 ± 1.80 mg/L by the strain grown on a yeast extract peptone dextrose (YPD)–rich medium. In contrast, the highest content of DCW reached 3.20 ± 0.11 mg/g using a synthetic yeast nitrogen base (YNB) medium to culture the cells. Over 18.0 g/L of citric acid was detected in the supernatant of the YPD medium at the end of cultivation. Furthermore, the zeaxanthin-producing strains still accumulated a large amount of lycopene and β-carotene. The results demonstrated the potential of a cell factory for zeaxanthin biosynthesis and opened up an avenue to engineer this host for the overproduction of carotenoids.

scholarly journals A metabolic reconstruction of Lactobacillus reuteri JCM 1112 and analysis of its potential as a cell factory

2019 ◽  
Vol 18 (1) ◽  
Author(s):  
Thordis Kristjansdottir ◽  
Elleke F. Bosma ◽  
Filipe Branco dos Santos ◽  
Emre Özdemir ◽  
Markus J. Herrgård ◽  
...  
Keyword(s):  
Experimental Data ◽  
Metabolic Engineering ◽  
Growth Rates ◽  
Lactobacillus Reuteri ◽  
Metabolic Model ◽  
Metabolic Reconstruction ◽  
Cell Factory ◽  
A Genome ◽  
A Cell ◽  
Genome Scale

Abstract Background Lactobacillus reuteri is a heterofermentative Lactic Acid Bacterium (LAB) that is commonly used for food fermentations and probiotic purposes. Due to its robust properties, it is also increasingly considered for use as a cell factory. It produces several industrially important compounds such as 1,3-propanediol and reuterin natively, but for cell factory purposes, developing improved strategies for engineering and fermentation optimization is crucial. Genome-scale metabolic models can be highly beneficial in guiding rational metabolic engineering. Reconstructing a reliable and a quantitatively accurate metabolic model requires extensive manual curation and incorporation of experimental data. Results A genome-scale metabolic model of L. reuteri JCM 1112T was reconstructed and the resulting model, Lreuteri_530, was validated and tested with experimental data. Several knowledge gaps in the metabolism were identified and resolved during this process, including presence/absence of glycolytic genes. Flux distribution between the two glycolytic pathways, the phosphoketolase and Embden–Meyerhof–Parnas pathways, varies considerably between LAB species and strains. As these pathways result in different energy yields, it is important to include strain-specific utilization of these pathways in the model. We determined experimentally that the Embden–Meyerhof–Parnas pathway carried at most 7% of the total glycolytic flux. Predicted growth rates from Lreuteri_530 were in good agreement with experimentally determined values. To further validate the prediction accuracy of Lreuteri_530, the predicted effects of glycerol addition and adhE gene knock-out, which results in impaired ethanol production, were compared to in vivo data. Examination of both growth rates and uptake- and secretion rates of the main metabolites in central metabolism demonstrated that the model was able to accurately predict the experimentally observed effects. Lastly, the potential of L. reuteri as a cell factory was investigated, resulting in a number of general metabolic engineering strategies. Conclusion We have constructed a manually curated genome-scale metabolic model of L. reuteri JCM 1112T that has been experimentally parameterized and validated and can accurately predict metabolic behavior of this important platform cell factory.

Yeast as a Cell Factory

2000 ◽  
Vol 26 (9-10) ◽  
pp. 639 ◽  
Author(s):  
R.E Spier
Keyword(s):  
Cell Factory ◽  
A Cell
Sign in / Sign up

Export Citation Format

Share Document